219 related articles for article (PubMed ID: 29961212)
1. Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying.
Booysen E; Bezuidenhout M; van Staden ADP; Dimitrov D; Deane SM; Dicks LMT
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):310-316. PubMed ID: 29961212
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.
Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC
World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains.
Simon A; Moreira MLA; Costa IFJB; de Sousa VP; Rodrigues CR; da Rocha E Lima LMT; Sisnande T; do Carmo FA; Leal ICR; Dos Santos KRN; da Silva LCRP; Cabral LM
Nanotechnology; 2020 Sep; 31(37):375101. PubMed ID: 32470951
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].
Herrera MT; Artunduaga JJ; Ortiz CC; Torres RG
Biomedica; 2017 Jan; 37(1):11-21. PubMed ID: 28527243
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of methicillin-resistant
Qiu Y; Wu Y; Lu B; Zhu G; Gong T; Wang R; Peng Q; Li Y
Biofouling; 2020 Feb; 36(2):159-168. PubMed ID: 32182142
[TBL] [Abstract][Full Text] [Related]
6. Demineralized bone matrix paste formulated with biomimetic PLGA microcarriers for the vancomycin hydrochloride controlled delivery: Release profile, citotoxicity and efficacy against S. aureus.
Govoni M; Lamparelli EP; Ciardulli MC; Santoro A; Oliviero A; Palazzo I; Reverchon E; Vivarelli L; Maso A; Storni E; Donati ME; Ruspaggiari G; Maffulli N; Fini M; Della Porta G; Dallari D
Int J Pharm; 2020 May; 582():119322. PubMed ID: 32298742
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
8. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles.
Kalhapure RS; Mocktar C; Sikwal DR; Sonawane SJ; Kathiravan MK; Skelton A; Govender T
Colloids Surf B Biointerfaces; 2014 May; 117():303-11. PubMed ID: 24667076
[TBL] [Abstract][Full Text] [Related]
9. Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies.
Sonawane SJ; Kalhapure RS; Rambharose S; Mocktar C; Vepuri SB; Soliman M; Govender T
Int J Pharm; 2016 May; 504(1-2):1-10. PubMed ID: 26992817
[TBL] [Abstract][Full Text] [Related]
10. Novel intracellular antibiotic delivery system against
Lacoma A; Usón L; Mendoza G; Sebastián V; Garcia-Garcia E; Muriel-Moreno B; Domínguez J; Arruebo M; Prat C
Nanomedicine (Lond); 2020 May; 15(12):1189-1203. PubMed ID: 32370602
[No Abstract] [Full Text] [Related]
11. A reformative shear precipitation procedure for the fabrication of vancomycin-loaded poly(lactide-co-glycolide) microspheres.
Wang L; Yang Q; Chen Y; Chai Y; Li JJ; Du L; Tan R; Yang S; Tu M; Yu B
J Biomater Appl; 2017 Feb; 31(7):995-1009. PubMed ID: 28068861
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
13. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M
Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313
[TBL] [Abstract][Full Text] [Related]
14. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin.
Kalhapure RS; Jadhav M; Rambharose S; Mocktar C; Singh S; Renukuntla J; Govender T
Colloids Surf B Biointerfaces; 2017 Oct; 158():650-657. PubMed ID: 28763772
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and antibacterial activity of juglone encapsulated PLGA nanoparticles.
Arasoglu T; Derman S; Mansuroglu B; Yelkenci G; Kocyigit B; Gumus B; Acar T; Kocacaliskan I
J Appl Microbiol; 2017 Dec; 123(6):1407-1419. PubMed ID: 28980369
[TBL] [Abstract][Full Text] [Related]
17. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
18. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
19. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.
Pei Y; Mohamed MF; Seleem MN; Yeo Y
J Control Release; 2017 Dec; 267():133-143. PubMed ID: 28797580
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections.
Arayici PP; Coksu I; Ozbek T; Acar S
Biomater Adv; 2024 Jul; 161():213862. PubMed ID: 38678666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
